Welly Travel Medicine Kit
NDC Package 72663-205-48
Package Information
Welly Travel Medicine Kit is to prevent motion sickness, take the first dose ½ hour to 1 hour before starting activityto treat motion sickness, take at first signs of symptomsadults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor do not take more than directedthe smallest effective dose should be usedadults and children 12 years and over: take 1 tablet every 4 to 6 hours while symptoms persistIf pain or fever does not respond to 1 tablet, 2 tablets may be useddo not exceed 6 tablets in 24 hours, unless directed by a doctorchildren under 12 years: ask a doctor chew or crush tablets completely before swallowing; do not swallow tablets wholeadults: take 1 or 2 chewable tablets as needed after meals and at bedtimedo not exceed 4 chewable tablets in 24 hours unless directed by a doctor drink plenty of clear fluids to help prevent dehydration caused by diarrheafind right dose on chart. Marketed by Welly Health Pbc, this product is identified by NDC 72663-205 and is authorized under FDA application part336.
Identification & Billing
- RxCUI: 1101446 - doxylamine succinate 25 MG Oral Tablet
- RxCUI: 310965 - ibuprofen 200 MG Oral Tablet
- RxCUI: 310965 - ibuprofen 200 MG (as ibuprofen sodium 256 MG) Oral Tablet
- RxCUI: 314221 - simethicone 125 MG Chewable Tablet
- RxCUI: 978010 - loperamide HCl 2 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72663 - Welly Health Pbc
- 72663-205 - Welly Travel Medicine Kit
- 72663-205-48 - 1 KIT in 1 KIT * 2 BLISTER PACK in 1 KIT (72663-746-48) / 6 TABLET, CHEWABLE in 1 BLISTER PACK * 12 TABLET in 1 BLISTER PACK (72663-567-48) * 8 TABLET in 1 BLISTER PACK (72663-369-48) * 16 TABLET in 1 BOTTLE (72663-428-48) * 8 TABLET in 1 BLISTER PACK (72663-632-48)
- 72663-205 - Welly Travel Medicine Kit
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72663-205-48 identifies a specific commercial package of 1 kit in 1 kit * 2 blister pack in 1 kit (72663-746-48) / 6 tablet, chewable in 1 blister pack * 12 tablet in 1 blister pack (72663-567-48) * 8 tablet in 1 blister pack (72663-369-48) * 16 tablet in 1 bottle (72663-428-48) * 8 tablet in 1 blister pack (72663-632-48) of Welly Travel Medicine Kit, labeled by Welly Health Pbc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Welly Health Pbc on April 06, 2020. The current certification is valid through December 31, 2021.
How is this Welly Health Pbc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72663020548. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.